Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17241857 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Mesalazine Therapy in Patients With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Interventions: Drug: Mesalazine;   Drug: Placebo

Indicates status has not been verified in more than two years